Condition
Pilonidal Sinus Disorder
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06721169Recruiting
Phenol or Laser: Best Minimally Invasive Treatment for Pilonidal Sinus?
NCT07370714RecruitingPrimary
Factors Affecting Wound Dehiscence in Pilonidal Sinus Surgery (ORIPIS)
NCT07260643Not Yet RecruitingPrimary
SiLaC Laser Technique for Pilonidal Sinus - La Paz Cohort Study.
NCT02638064Not ApplicableCompletedPrimary
Treatment of Pilonidal Sinus Disease Using Surgiflo as a Sealant: A New Concept
Showing all 4 trials